Patients who took the Stribild HIV medication have suffered a variety of side effects and some people have chosen to come forward and lodge complaints. If you took the Stribild HIV medication and suffered unfortunate and unexpected side effects, like kidney or bone complications, you could be eligible to participate in a class action lawsuit investigation.

Any patient who receives a medication to treat a condition is aware of the possibility of side effects. But when numerous patients begin to realize they are undergoing severe symptoms they weren’t told about, they may have a legal claim.

Several lawsuits have already been filed over Stribild HIV medication due to patients who experienced kidney or bone problems after taking any medication that contains the ingredient tenofovir disoproxil fumarate, also known as TDF. Patients have alleged that the Stribild HIV drug manufacturers failed to properly warn patients about the kidney and bone risks connected with TDF.

Furthermore, the Stribild HIV drug lawsuits have accused creator Gilead Sciences of purposely withholding a safer medication known as TAF from the market until they have received maximum profits from the Stribild HIV drug format.

TDF Drugs

TDF drugs, a common class of HIV medications, have been linked to kidney problems and bone density issues and patients accuse the manufacturer of failing to warn them about these dangerous side effects and keeping the drug on the market longer than necessary.

Patients who took this drug and several others have begun to report serious side effects, and they say that the company is accountable for the injuries they have already sustained and will continue to suffer in the future. Some of those patients are evaluating their rights to file defective product claims with the help of a lawyer.

When a drug on the market fails to include details about the severe side effects that should have been disclosed, patients might take legal action.

Other medications, including Viread, Complera, and Atripla, are also associated with the problems linked with the Stribild HIV drug. According to allegations from consumers who took the medication, these drugs lead to kidney failure, kidney damage, and chronic kidney disease.

Furthermore, some patients who took the Stribild HIV medication have experienced bone demineralization. One Gilead lawsuit filed in July 2018 accuses the manufacturer of failing to warn patients about the fact that these medicines are not absorbed very well. This particular lawsuit alleges that the HIV medications must be ingested at high doses in order to provide the advertised anti-viral effect.

Many different patients including those who took the Stribild HIV drug claim that they were never told about the possible dangers in advance and therefore not able to make an informed decision about whether or not to use the medication based on the bone and kidney issues connected to the regular use of the drug.

If you or someone you know has been taking Stribild HIV drugs and has suffered critical side effects affecting bones or kidneys after taking the drug as prescribed, you could have grounds to participate in a Stribild HIV drug lawsuit investigation.